Latest Financials News

Findi Limited has reported record FY25 revenue and EBITDA growth, driven by key acquisitions and expanded ATM and digital payment networks across India. The company’s strengthened balance sheet and contract wins set the stage for its subsidiary’s planned 2026 IPO.

Findi Ltd reports flat revenue and a 15% rise in EBITDA but swings to a $12.5 million net loss for FY2025, driven by strategic capital raises and refinancing in its Indian subsidiary.

NRW Holdings’ subsidiary Primero Group has landed a $157 million contract from Rio Tinto to deliver critical infrastructure at Hope Downs in Western Australia, extending their longstanding partnership.

Aspermont Limited reports steady subscription growth with $11.2 million in annual recurring revenue despite a dip in total revenue, while gearing up for new data product launches and an IPO.

The Arkansas Oil & Gas Commission has approved a 2.5% lithium royalty for brine projects, providing Pantera Lithium with regulatory clarity and a competitive fiscal framework that enhances its Smackover Project’s commercial prospects.

Lord Resources Limited has announced a pro-rata non-renounceable entitlement issue to raise approximately $1.39 million, primarily to fund exploration at its Ilgarari Copper Project. The offer presents both opportunity and risk for shareholders amid ongoing funding needs and exploration uncertainties.

Meeka Metals is on track to commission its upgraded processing plant at the Murchison Gold Project by June 2025, aiming for first gold production shortly thereafter. The company has also expanded its workforce accommodations and advanced underground mine preparations.

HealthCo Healthcare & Wellness REIT and its partners have arranged a short-term partial rent deferral with Healthscope’s receivers to maintain hospital operations during a critical transition period.

Aspermont has reported a 6% rise in revenue and a 25% jump in net profit for the half year ending March 2025, yet its net tangible assets per share have declined and dividends remain on hold.

Chorus Limited’s 2024 fibre regulatory report reveals a stable $5.9 billion asset base and revenue close to the maximum allowed, with a $153.5 million wash-up balance carried forward.

Pacific Edge Limited has launched a NZ$20 million capital raise to bolster its cash reserves amid the loss of Medicare coverage for its bladder cancer diagnostic tests, aiming to accelerate US market adoption and support new product development.

Pacific Edge Limited reported a resilient FY25 performance despite losing Medicare coverage for its Cxbladder tests in the US, announcing a $20 million equity raise to support commercialization and growth.